Trimi vs Embody: Pricing, Shipping, and Care Compared

Quick verdict: Trimi vs Embody favors Embody for the lowest entry price and fastest 1-2 day delivery, while Trimi stands out for flat same-price dosing, named compounding pharmacies, and a 6-month money-back promise. Both use compounded semaglutide and tirzepatide prescribed by licensed clinicians and note compounded medications are not FDA-approved.

How Trimi and Embody compare: overview

This Trimi vs Embody comparison focuses on the most distinctive differences supported by the source: price and plan structure, shipping speed and delivery promise, medical and pharmacy oversight, refund and commitment policies, and the compounded medication regulatory note. I compare each criterion directly so you can pick the program that matches your priorities.

Price and plan structure

Embody advertises a lower entry price: semaglutide at $69/month and tirzepatide at $119/month, with $69 listed as cut from $299. Embody highlights no membership and cancel anytime. Trimi lists semaglutide from $99/month on the annual plan and tirzepatide at $125/month, and emphasizes flat pricing that never rises as dose increases. Trimi also promotes a single flat membership that covers medication, clinician visits, and free shipping on annual plans.

View Embody’s $69/month offer

Shipping speed and delivery

Embody promises free shipping that arrives in 1 to 2 days after clinician approval. Trimi advertises free overnight, temperature-controlled shipping. Both providers state free shipping, but Embody emphasizes a 1-2 day delivery window while Trimi highlights overnight and temperature-controlled handling.

Medical oversight and pharmacy sourcing

Trimi states prescriptions are written by US-licensed clinicians through Arora Health, led by a board-certified physician, and that medications are compounded by state-licensed 503A pharmacies, including named pharmacies with certificates of analysis available on request. Embody describes licensed telehealth provider review and fulfillment by a licensed pharmacy but does not list specific pharmacy names in the captured evidence.

Commitments, refunds, and membership terms

Embody promotes no monthly membership and the ability to cancel anytime, framing its model as no long-term commitment. Trimi highlights an annual plan pricing structure and a 6-month money-back promise: follow the plan for 6 months and you may request a refund if you do not lose weight, with terms applying. Trimi also mentions automatic refund if not approved by their medical team. These differences affect flexibility and risk tolerance.

Regulatory note and medication status

Both providers state their medications are compounded and include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Trimi further notes that the peer-reviewed clinical trials behind the active ingredients are cited but are not a guarantee of individual results. Embody notes its compounded medications use the same active ingredients as branded options and that final pricing may vary based on clinician recommendation.

Side-by-side comparison table

Other practical differences

Embody targets cost-driven patients who want a straightforward program without premium add-ons and highlights 24/7 support access for dosing and side-effect questions in captured bullets. Trimi emphasizes named compounding pharmacies, temperature control in shipping, and an explicit clinical network for medical oversight. Both providers indicate final eligibility, pricing, and state availability may vary and that compounded medications are prescribed after clinician review.

Start Embody clinician review

Conclusion and who should choose which provider

In this Trimi vs Embody comparison, choose Embody if lowest entry price and fastest 1-2 day delivery matter most and you prefer no membership commitment. Choose Trimi if you value same-price dosing at every dose, named compounding pharmacies and temperature-controlled overnight shipping, plus a 6-month money-back promise and explicit clinical oversight via Arora Health. Both use compounded semaglutide and tirzepatide prescribed by licensed clinicians and note compounded medications are not FDA-approved.